Li Wei, Yu-Kai Su, Chien-Min Lin, Tsu-Yi Chao, Shang-Pen Huang, Thanh-Tuan Huynh, Hsun-Jin Jan, Jacqueline Whang-Peng, Jeng-Fong Chiou, Alexander T.H. Wu, Michael Hsiao
Preclinical investigation of ibrutinib, a Bruton’s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes
Oncotarget. 2016; 7:69961-69975. https://doi.org/10.18632/oncotarget.11572 (IF: not available, Oncology).

Shang-Pen Huang, Pei-Yao Liu, Chih-Jung Kuo, Chi-Long Chen, Wei-Jiunn Lee, Yu-Hui Tsai, Yuan-Feng Lin
The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer
Journal of Hematology & Oncology. 2017; 10:114 (IF: 23.168, Hematology: 4/78).

Shang-Pen Huang, Yu-Chan Chang, Qie Hua Low, Alexander T.H. Wu, Chi-Long Chen, Yuan-Feng Lin, Michael Hsiao
BICD1 expression, as a Potential Biomarker for Predicting the Prognosis and Response to Therapy in Glioblastoma patients
Oncotarget. 2017; 8(69):113766-113791. doi: 10.18632/oncotarget.22667 (IF: not available, Oncology).

Shang-Pen Huang, Jean Chiou, Yi-Hua Jan, Tsung-Ching Lai, Yung-Luen Yu, Michael Hsiao, Yuan-Feng Lin

Over-expression of Lysyl Oxidase is associated with poor prognosis and response to therapy of patients with lower grade gliomas
Biochemical and Biophysical Research Communication. 2018; 501(3):619-627. (IF: 3.322, Biophysics: 39/72)

Yu-Chan Chang, Hsing-Fang Tsai, Shang-Pen Huang, Chi-Long Chen, Michael Hsiao, Wen-Chiuan Tsai
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas.
Cancers (Basel). 2019 Aug 23;11(9). (IF: 6.575, Oncology: 60/245).

Shang-Pen Huang, Yung-Chieh Chan, Shang-Yu Huang, Yuan-Feng Lin
Overexpression of PSAT1 Gene is a Favorable Prognostic Marker in Lower-Grade Gliomas and Predicts a Favorable Outcome in Patients with IDH1 Mutations and Chromosome 1p19q Codeletion
Cancers (Basel). 2019 Dec 18;12(1). (IF: 6.575, Oncology: 60/245).